Rankings
▼
Calendar
SAVA Q2 2021 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SAVA
Cassava Sciences, Inc.
$115M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$4M
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-0.13
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$415,000
Balance Sheet
Total Assets
$281M
Total Liabilities
$5M
Stockholders' Equity
$276M
Cash & Equivalents
$278M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$4M
-$591,000
-560.1%
Operating Income
-$5M
-$1M
-341.8%
Net Income
-$5M
-$1M
-351.1%
← FY 2021
All Quarters
Q3 2021 →